<DOC>
	<DOCNO>NCT02128984</DOCNO>
	<brief_summary>The purpose study determine whether nutritional supplement effective treatment malnutrition pediatric patient failure thrive cystic fibrosis .</brief_summary>
	<brief_title>Clinical Study With Enteral Formula With Symbiotic DHA Malnourished Children</brief_title>
	<detailed_description>This multicenter , control , randomize , prospective , parallel-group , double-blind study evaluate effect nutritional supplement nutritional status child failure thrive cystic fibrosis . Patients randomize receive either symbiotic formula DHA antioxidants standard formula .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Failure Thrive</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Malnutrition ( P / T &lt; 1 SD ) intake deficit without organic disease ( failure thrive ) / patient diagnose Cystic Fibrosis ) . Age &gt; = 1 year . Stable patient No antibiotherapy last 30 day Inform consent sign ( parent/legal representative ) Patients allergy / intolerance cow 's milk proteins Metabolically unstable patient Patients metabolic intolerance carbohydrates Patients severe disease last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Malnutrition</keyword>
	<keyword>Dietary supplement</keyword>
	<keyword>Nutritional supplement</keyword>
	<keyword>Symbiotic formula</keyword>
	<keyword>DHA</keyword>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Failure Thrive</keyword>
</DOC>